China Universal Asset Management Co., Ltd.
Position in NAMS — NewAmsterdam Pharma Co N.V.
CIK 1906594
SHANGHAI, F4
Position in NAMS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,647,223
+$248,290 QoQ
Shares Held
48,605
+11.2% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#96
of 197 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026China Universal Asset Management Co., Ltd. holds $180,189,557 across 240 Biotechnology names. NAMS ranks #24 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
48,265 | $23,974,673 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,498 | $12,157,782 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
25,269 | $7,606,727 | |
| 4 | RPRX |
Royalty Pharma plc
|
120,547 | $6,759,070 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
33,835 | $6,336,618 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
76,302 | $6,049,985 | |
| 7 | MRNA |
Moderna, Inc.
|
63,149 | $4,422,324 | |
| 8 | ARGX |
Argenx SE
|
4,642 | $4,306,708 |
All Filings in NAMS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,647,223 | 48,605 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,398,933 | 43,703 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $928,813 | 26,477 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $561,462 | 19,742 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $408,362 | 22,549 | Shares | Sole | 2025-08-28 | |
| 2025-03-31 | $450,913 | 22,028 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $503,437 | 19,589 | Shares | Sole | 2025-01-24 | |
| No filing history on record for this holder in this stock. | ||||||